KAM
GCVRZ

Knightsbridge Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Knightsbridge Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27,400
Closed -$5K – 42
2015
Q3 		$5K Sell
27,400
-30,800
-53% -$10.5K ﹤0.01% 39
2015
Q2 		$41K Hold
58,200
– – 0.02% 45
2015
Q1 		$39K Hold
58,200
– – 0.02% 46
2014
Q4 		$46K Sell
58,200
-16,500
-22% -$11.3K 0.01% 51
2014
Q3 		$35K Hold
74,700
– – 0.01% 50
2014
Q2 		$37K Hold
74,700
– – 0.01% 47
2014
Q1 		$23K Sell
74,700
-900
-1% -$335 0.01% 45
2013
Q4 		$26K Sell
75,600
-42,100
-36% -$50.9K 0.01% 44
2013
Q3 		$238K Hold
117,700
– – 0.06% 42
2013
Q2 		$224K Buy
+117,700
New +$207K 0.05% 40

Other funds holding GCVRZ

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Knightsbridge Asset Management's GCVRZ Position: Q4 2015 in Review

Knightsbridge Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 27,400 shares — an estimated $5K sold.

Knightsbridge Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 10 quarters. The position peaked at $238K in Q3 2013. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Knightsbridge Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Knightsbridge Asset Management sold 27,400 Sanofi Contingent Value Rights shares in Q4 2015, an estimated $5K.
  • Knightsbridge Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 10 quarters.
  • Knightsbridge Asset Management's Sanofi Contingent Value Rights position peaked at $238K in Q3 2013.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Knightsbridge Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.